Suppr超能文献

细胞色素P450酶与外源性和内源性底物作用的交叉:与毒性和药物相互作用的相关性

Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.

作者信息

Guengerich F Peter

机构信息

Department of Biochemistry, Vanderbilt University School of Medicine , Nashville, Tennessee 37232-0146, United States.

出版信息

Chem Res Toxicol. 2017 Jan 17;30(1):2-12. doi: 10.1021/acs.chemrestox.6b00226. Epub 2016 Aug 11.

Abstract

Today much is known about cytochrome P450 (P450) enzymes and their catalytic specificity, but the range of reactions catalyzed by each still continues to surprise. Historically, P450s had been considered to be involved in either the metabolism of xenobiotics or endogenous chemicals, in the former case playing a generally protective role and in the latter case a defined physiological role. However, the line of demarcation is sometimes blurred. It is difficult to be completely specific in drug design, and some P450s involved in the metabolism of steroids and vitamins can be off-targets. In a number of cases, drugs have been developed that act on some of those P450s as primary targets, e.g., steroid aromatase inhibitors. Several of the P450s involved in the metabolism of endogenous substrates are less specific than once thought and oxidize several related structures. Some of the P450s that primarily oxidize endogenous chemicals have been shown to oxidize xenobiotic chemicals, even in a bioactivation mode.

摘要

如今,人们对细胞色素P450(P450)酶及其催化特异性已有很多了解,但每种酶所催化的反应范围仍不断令人惊讶。从历史上看,P450s被认为要么参与外源性物质的代谢,要么参与内源性化学物质的代谢,在前一种情况下通常起保护作用,在后一种情况下起明确的生理作用。然而,界限有时会模糊不清。在药物设计中很难做到完全特异性,一些参与类固醇和维生素代谢的P450s可能成为脱靶靶点。在许多情况下,已经开发出一些作用于某些此类P450s作为主要靶点的药物,例如类固醇芳香化酶抑制剂。一些参与内源性底物代谢的P450s比人们曾经认为的特异性更低,会氧化几种相关结构。一些主要氧化内源性化学物质的P450s已被证明能氧化外源性化学物质,甚至以生物活化模式进行氧化。

相似文献

1
Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
Chem Res Toxicol. 2017 Jan 17;30(1):2-12. doi: 10.1021/acs.chemrestox.6b00226. Epub 2016 Aug 11.
2
Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
Arch Toxicol. 2021 Feb;95(2):395-472. doi: 10.1007/s00204-020-02971-4. Epub 2021 Jan 18.
3
Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
Curr Drug Metab. 2009 Sep;10(7):700-12. doi: 10.2174/138920009789895525.
4
Novel extrahepatic cytochrome P450s.
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):57-61. doi: 10.1016/j.taap.2004.12.022.
6
Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
Crit Rev Toxicol. 2007 Jun;37(5):389-412. doi: 10.1080/10408440701215233.
7
Recent Structural Insights into Cytochrome P450 Function.
Trends Pharmacol Sci. 2016 Aug;37(8):625-640. doi: 10.1016/j.tips.2016.05.006. Epub 2016 Jun 4.
8
Polymorphism of cytochrome P450 and xenobiotic toxicity.
Toxicology. 2002 Dec 27;181-182:447-52. doi: 10.1016/s0300-483x(02)00492-4.
9
Cytochromes P450 in the bioactivation of chemicals.
Curr Top Med Chem. 2004;4(16):1767-88. doi: 10.2174/1568026043387188.

引用本文的文献

1
Obesity-related drug-metabolizing enzyme expression alterations in the human liver.
Biomed Pharmacother. 2025 Jun;187:118155. doi: 10.1016/j.biopha.2025.118155. Epub 2025 May 12.
2
Editorial for the Special Issue "Cytochrome P450 (CYP) in Health and Disease".
Biomedicines. 2025 Apr 15;13(4):965. doi: 10.3390/biomedicines13040965.
3
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation.
J Xenobiot. 2025 Mar 14;15(2):44. doi: 10.3390/jox15020044.
5
SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson's disease.
Front Pharmacol. 2024 Sep 30;15:1477009. doi: 10.3389/fphar.2024.1477009. eCollection 2024.
6
Engineering Electron Transfer Pathway of Cytochrome P450s.
Molecules. 2024 May 24;29(11):2480. doi: 10.3390/molecules29112480.
7
Alteration of Hepatic Cytochrome P450 Expression and Arachidonic Acid Metabolism by Arsenic Trioxide (ATO) in C57BL/6 Mice.
Biol Trace Elem Res. 2025 Feb;203(2):1000-1015. doi: 10.1007/s12011-024-04225-1. Epub 2024 May 17.
9
Mutual Modulation of the Activities of Human CYP2D6 and Four UGTs during the Metabolism of Propranolol.
Curr Issues Mol Biol. 2023 Aug 26;45(9):7130-7146. doi: 10.3390/cimb45090451.
10
SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson's disease.
Front Pharmacol. 2023 Aug 4;14:1244516. doi: 10.3389/fphar.2023.1244516. eCollection 2023.

本文引用的文献

2
Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells.
Mol Cell Proteomics. 2016 Oct;15(10):3233-3242. doi: 10.1074/mcp.M116.059709. Epub 2016 Aug 8.
4
Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.
J Lipid Res. 2016 Aug;57(8):1552-63. doi: 10.1194/jlr.M069229. Epub 2016 Jun 16.
6
Recent Structural Insights into Cytochrome P450 Function.
Trends Pharmacol Sci. 2016 Aug;37(8):625-640. doi: 10.1016/j.tips.2016.05.006. Epub 2016 Jun 4.
7
Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.
J Biol Chem. 2016 May 27;291(22):11876-86. doi: 10.1074/jbc.M116.723577. Epub 2016 Apr 7.
8
Toxicology Strategies for Drug Discovery: Present and Future.
Chem Res Toxicol. 2016 Apr 18;29(4):473-504. doi: 10.1021/acs.chemrestox.5b00407. Epub 2015 Dec 4.
9
Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.
J Med Chem. 2016 May 12;59(9):4210-20. doi: 10.1021/acs.jmedchem.5b01146. Epub 2015 Sep 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验